Department of Nuclear Medicine and PET Research, VU University Medical Center, Amsterdam, The Netherlands.
J Nucl Med. 2013 Sep;54(9):1570-6. doi: 10.2967/jnumed.112.113654. Epub 2013 Aug 12.
Several methods are in use for analyzing (11)C-Pittsburgh compound-B ((11)C-PiB) data. The objective of this study was to identify the method of choice for measuring longitudinal changes in specific (11)C-PiB binding.
Dynamic 90-min (11)C-PiB baseline and follow-up scans (interval, 30 ± 5 mo) were obtained for 7 Alzheimer disease (AD) patients, 11 patients with mild cognitive impairment (MCI), and 11 healthy controls. Parametric images were generated using reference parametric mapping (RPM2), reference Logan values, and standardized uptake value volume ratios (SUVr), the latter for intervals between 60 and 90 (SUVr(60-90)) and 40 and 60 (SUVr(40-60)) minutes after injection. In all analyses, cerebellar gray matter was used as a reference region. A global cortical volume of interest was defined using a probability map-based template. Percentage change between baseline and follow-up was derived for all analytic methods.
SUVr(60-90) and SUVr(40-60) overestimated binding with 13% and 10%, respectively, compared with RPM2. Reference Logan values were on average 6% lower than RPM2. Both SUVr measures showed high intersubject variability. Over time, R1, the delivery of tracer to the cortex relative to that to the cerebellum, decreased in AD patients (P < 0.05) but not in MCI patients and controls. Simulations showed that SUVr, but not RPM2 and reference Logan values, was highly dependent on uptake period and that changes in SUVr over time were sensitive to changes in flow.
To reliably assess amyloid binding over time--for example, in drug intervention studies--it is essential to use fully quantitative methods for data acquisition and analysis.
有几种方法可用于分析(11)C-Pittsburgh 化合物-B((11)C-PiB)数据。本研究的目的是确定测量特定(11)C-PiB 结合纵向变化的首选方法。
对 7 名阿尔茨海默病(AD)患者、11 名轻度认知障碍(MCI)患者和 11 名健康对照者进行 90 分钟动态(11)C-PiB 基线和随访扫描(间隔 30±5 个月)。使用参考参数映射(RPM2)、参考 Logan 值和标准化摄取量体积比(SUVr)生成参数图像,后者用于注射后 60 至 90(SUVr(60-90))和 40 至 60(SUVr(40-60))分钟之间的间隔。在所有分析中,小脑灰质均用作参考区域。使用基于概率图的模板定义整个皮质体积感兴趣区。根据所有分析方法,从基线到随访均推导了百分比变化。
与 RPM2 相比,SUVr(60-90)和 SUVr(40-60)分别高估了 13%和 10%的结合。参考 Logan 值平均比 RPM2 低 6%。两种 SUVr 测量值均表现出高度的个体间变异性。随着时间的推移,AD 患者大脑皮层相对于小脑的示踪剂输送率(R1)降低(P<0.05),而 MCI 患者和对照组则没有。模拟表明,SUVr 但不是 RPM2 和参考 Logan 值高度依赖于摄取期,并且 SUVr 随时间的变化对流量的变化敏感。
为了可靠地随时间评估淀粉样蛋白结合情况(例如,在药物干预研究中),必须使用完全定量的方法进行数据采集和分析。